arginine has been researched along with Paramyxoviridae Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, MC; Boivin, G; Couture, C; Hamelin, MÈ; Jandrot-Perrus, M; Lê, VB; Rhéaume, C; Riteau, B | 1 |
| Boivin, G; Checkmahomed, L; Couture, C; Hamelin, MÈ; Jandrot-Perrus, M; Lê, BV; Venable, MC | 1 |
2 other study(ies) available for arginine and Paramyxoviridae Infections
| Article | Year |
|---|---|
Protease-activated receptor 1 inhibition protects mice against thrombin-dependent respiratory syncytial virus and human metapneumovirus infections.
Topics: Animals; Arginine; Cells, Cultured; Female; Humans; Indazoles; Metapneumovirus; Mice; Oligopeptides; Paramyxoviridae Infections; Pipecolic Acids; Receptor, PAR-1; Respiratory Syncytial Virus, Human; Sulfonamides; Thrombin; Urea; Virus Replication; Weight Loss | 2018 |
Evaluation of anticoagulant agents for the treatment of human metapneumovirus infection in mice.
Topics: Animals; Anticoagulants; Arginine; Disease Models, Animal; Heparin; Metapneumovirus; Mice; Paramyxoviridae Infections; Pipecolic Acids; Sulfonamides; Survival Analysis; Treatment Outcome; Viral Load; Virus Replication; Warfarin | 2018 |